These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31098947)

  • 41. Who cares about cost? Does economic analysis impose or reflect social values?
    Nord E; Richardson J; Street A; Kuhse H; Singer P
    Health Policy; 1995 Nov; 34(2):79-94. PubMed ID: 10153484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Economic evaluation in critical care medicine.
    Cox HL; Laupland KB; Manns BJ
    J Crit Care; 2006 Jun; 21(2):117-24. PubMed ID: 16769454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are intersectoral costs considered in economic evaluations of interventions relating to sexually transmitted infections (STIs)? A systematic review.
    Schnitzler L; Evers SMAA; Jackson LJ; Paulus ATG; Roberts TE
    BMC Public Health; 2022 Nov; 22(1):2180. PubMed ID: 36434561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rationing health care: from needs to markets? The politics of destruction: rationing in the UK health care market.
    Pollock AM
    Health Care Anal; 1995 Nov; 3(4):299-308; discussion 309-14. PubMed ID: 10156208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Using economic evaluations to reduce the burden of asthma and chronic obstructive pulmonary disease.
    Sculpher M
    Pharmacoeconomics; 2001; 19 Suppl 2():21-5. PubMed ID: 11700785
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness analysis and formulary decision making in England: findings from research.
    Williams IP; Bryan S
    Soc Sci Med; 2007 Nov; 65(10):2116-29. PubMed ID: 17698271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Economic Evaluation in Ethiopian Healthcare Sector Decision Making: Perception, Practice and Barriers.
    Zegeye EA; Mbonigaba J; Kaye SB; Wilkinson T
    Appl Health Econ Health Policy; 2017 Feb; 15(1):33-43. PubMed ID: 27637919
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Decision support through economic evaluation from the perspective of science in Germany].
    Graf von der Schulenburg JM
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):660-7. PubMed ID: 22526854
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CONCEPTUALIZATIONS OF THE SOCIETAL PERSPECTIVE WITHIN ECONOMIC EVALUATIONS: A SYSTEMATIC REVIEW.
    Drost RMWA; van der Putten IM; Ruwaard D; Evers SMAA; Paulus ATG
    Int J Technol Assess Health Care; 2017 Jan; 33(2):251-260. PubMed ID: 28641592
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sustainability in health care by allocating resources effectively (SHARE) 3: examining how resource allocation decisions are made, implemented and evaluated in a local healthcare setting.
    Harris C; Allen K; Waller C; Brooke V
    BMC Health Serv Res; 2017 May; 17(1):340. PubMed ID: 28486953
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Value for money in the health sector: the contribution of primary health care.
    Mills A; Drummond M
    Health Policy Plan; 1987 Jun; 2(2):107-28. PubMed ID: 10312103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Controlling Healthcare Costs: Just Cost Effectiveness or "Just" Cost Effectiveness?
    Fleck LM
    Camb Q Healthc Ethics; 2018 Apr; 27(2):271-283. PubMed ID: 29509125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early assessment of medical technologies to inform product development and market access: a review of methods and applications.
    Ijzerman MJ; Steuten LM
    Appl Health Econ Health Policy; 2011 Sep; 9(5):331-47. PubMed ID: 21875163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Morality and the limits of societal values in health care allocation.
    Walker RL; Siegel AW
    Health Econ; 2002 Apr; 11(3):265-73. PubMed ID: 11921322
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tools of the trade: a comparative analysis of approaches to priority setting in healthcare.
    Mitton C; Donaldson C
    Health Serv Manage Res; 2003 May; 16(2):96-105. PubMed ID: 12803949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence.
    Brunetti M; Shemilt I; Pregno S; Vale L; Oxman AD; Lord J; Sisk J; Ruiz F; Hill S; Guyatt GH; Jaeschke R; Helfand M; Harbour R; Davoli M; Amato L; Liberati A; Schünemann HJ
    J Clin Epidemiol; 2013 Feb; 66(2):140-50. PubMed ID: 22863410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quality-adjusted life-years. Ethical implications for physicians and policymakers.
    La Puma J; Lawlor EF
    JAMA; 1990 Jun; 263(21):2917-21. PubMed ID: 2110986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Managing healthcare budgets in times of austerity: the role of program budgeting and marginal analysis.
    Mitton C; Dionne F; Donaldson C
    Appl Health Econ Health Policy; 2014 Apr; 12(2):95-102. PubMed ID: 24458477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Self-reported healthcare decision-makers' attitudes towards economic evaluations of medical technologies.
    Galani C; Rutten FF
    Curr Med Res Opin; 2008 Nov; 24(11):3049-58. PubMed ID: 18826747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk-based, 6-monthly and 24-monthly dental check-ups for adults: the INTERVAL three-arm RCT.
    Clarkson JE; Pitts NB; Goulao B; Boyers D; Ramsay CR; Floate R; Braid HJ; Fee PA; Ord FS; Worthington HV; van der Pol M; Young L; Freeman R; Gouick J; Humphris GM; Mitchell FE; McDonald AM; Norrie JD; Sim K; Douglas G; Ricketts D
    Health Technol Assess; 2020 Nov; 24(60):1-138. PubMed ID: 33215986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.